Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Kejin Biotechnology

Request full access

High-quality disposable consumables for life science laboratories

ChinaFounded 2015

About Shanghai Kejin Biotechnology

Shanghai Kejin Biotechnology Co., Ltd., operating under the brand Kirgen, is a high-tech enterprise founded in Shanghai in 2015. The company specializes in the research, development, production, and sale of disposable laboratory consumables. Kirgen has established itself as a manufacturer in the life sciences field, mastering new material technologies and polymer material modification to produce its product line.

The company's product portfolio is manufactured from medical-grade polypropylene using automated molding systems in a 100,000-grade clean environment to ensure products are DNase/RNase free and non-pyrogenic. Key product categories include pipette tips, robotic tips, centrifuge tubes, serological pipettes, cryogenic vials, and deep well plates, which are used for applications in molecular biology, cell culture and preservation, liquid handling, and in vitro diagnostics. Kirgen also offers OEM services to meet varied customer needs.

Operating on a global scale, Kirgen serves research institutions, medical organizations, clinical laboratories, and industrial units across the life science, pharmaceutical, and food safety sectors in over 65 countries. The company has an Asia Pacific headquarters in Shanghai to manage stock and logistics for the Greater China region and neighboring countries. It holds multiple certifications, including ISO 13485, ISO 9001, CE, and SFDA, underscoring its commitment to quality standards.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
12.0/100
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC May 2023 $14M $55M Addor Capital · Industrial Securities Capital · Yaojin Capital ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Kejin Biotechnology website traffic

Latest recorded traffic for Shanghai Kejin Biotechnology is 50 monthly website visits, down 98.4% over the last three months.

Latest monthly visits50 3-month web change-98.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Kejin Biotechnology in its local ecosystem

Live from Dealroom

The Shanghai Kejin Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Addor Capital
  • Industrial Securities Capital
  • Yaojin Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Kejin Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Kejin Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.